Xtrackers Switzerland UCITS ETF 1C is a equity ETF from Xtrackers tracking the Switzerland index through physical replication. Domiciled in Luxembourg and launched in 2013, the fund manages about 811 M € and charges a TER of 0.31% — 31 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Xtrackers Switzerland UCITS ETF 1C competes with 1 other products on the same index (Switzerland): it ranks 2nd by fund size and 1st by ongoing cost, with a TER of 0.31% against a group median of 0.31%. It has been listed since 2013, 13 years of track record.
On a €10,000 investment the TER costs 31 € a year. The cheapest of the group is Xtrackers Switzerland UCITS ETF 1D at 0.31%, or 31 € on the same amount: a difference of 0 € every year, roughly 0 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 84.1% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in CHF. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| Roche Holding AG | 16.6% |
| Novartis AG | 15.7% |
| Nestle S.A. | 14.4% |
| ABB Ltd | 9.4% |
| UBS Group AG | 8.1% |
| Compagnie Financière Richemont SA | 6.3% |
| Zurich Insurance Group AG | 5.9% |
| Holcim AG | 2.8% |
| Swiss Re AG | 2.5% |
| Lonza Group AG | 2.4% |
| SIX Swiss Exchange | XSMC | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.